Inherited and acquired disorders of myelin: The underlying myelin pathology

Experimental Neurology

Volumn 283, Issue , 2016, Pages 452-475

  Duncan, Ian D ^a   Radcliff, Abigail B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Deficiency; Demyelination; Leukodystrophy; Multiple sclerosis; Myelin vacuolation; Toxin

Indexed keywords

ASPARTOACYLASE; CEREBROSIDE SULFATASE; CUPRIZONE; ETHIDIUM BROMIDE; GALACTOSYLCERAMIDASE; HEXACHLOROPHENE; HYALURONIC ACID; INITIATION FACTOR 2; LYSOPHOSPHATIDYLCHOLINE; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; TRIETHYLTIN; VERY LONG CHAIN FATTY ACID; ZYMOSAN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADRENOLEUKODYSTROPHY; ALEXANDER DISEASE; CANAVAN DISEASE; CELL DEGENERATION; DEMYELINATING DISEASE; DEMYELINATION; ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL DEMYELINATION; FELINE IRRADIATED DIET INDUCED DEMYELINATION; GENE MUTATION; GLOBOID CELL LEUKODYSTROPHY; HUMAN; LYSOSOME STORAGE DISEASE; METACHROMATIC LEUKODYSTROPHY; MITOCHONDRION; MULTIPLE SCLEROSIS; MURINE HEPATITIS; MURINE HEPATITIS VIRUS; MYELIN DEFICIENCY; MYELIN SHEATH; MYELIN VACUOLATION; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; QUAKING MOUSE; RAT MUTANT; REMYELINIZATION; REVIEW; THEILER'S MURINE ENCEPHALOMYELITIS VIRUS; VANISHING WHITE MATTER DISEASE; VIRAL DEMYELINATION; WHITE MATTER LESION; ZITTER RAT; ANIMAL; COMPLICATION; GENETICS; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DEMYELINATING DISEASES; HUMANS; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA;

EID: 84964200231     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2016.04.002     Document Type: Review

References (253)

1. Adachi, M., Schneck, L., Cara, J., Volk, B.W., Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review. Hum. Pathol. 4 (1973), 331–347.
2. Agamanolis, D.P., Victor, M., Harris, J.W., Hines, J.D., Chester, E.M., Kark, J.A., An ultrastructural study of subacute combined degeneration of the spinal cord in vitamin B12-deficient rhesus monkeys. J. Neuropathol. Exp. Neurol. 37 (1978), 273–299.
3. Almad, A., Sahinkaya, F.R., McTigue, D.M., Oligodendrocyte fate after spinal cord injury. Neurotherapeutics 8 (2011), 262–273.
4. Aubourg, P., Axons need glial peroxisomes. Nat. Genet. 39 (2007), 936–938.
5. Back, S.A., Rosenberg, P.A., Pathophysiology of glia in perinatal white matter injury. Glia 62 (2014), 1790–1815.
6. Baker, D., O'Neill, J.K., Gschmeissner, S.E., Wilcox, C.E., Butter, C., Turk, J.L., Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28 (1990), 261–270.
7. Barnett, M.H., Prineas, J.W., Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004), 458–468.
8. Baron, W., Hoekstra, D., On the biogenesis of myelin membranes: sorting, trafficking and cell polarity. FEBS Lett. 584 (2010), 1760–1770.
9. Baskin, J.M., Wu, X., Christiano, R., Oh, M.S., Schauder, C.M., Gazzerro, E., Messa, M., Baldassari, S., Assereto, S., Biancheri, R., Zara, F., Minetti, C., Raimondi, A., Simons, M., Walther, T.C., Reinisch, K.M., De Camilli, P., The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane. Nat. Cell Biol. 18 (2016), 132–138.
10. Baslow, M.H., Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease — a mechanistic explanation. J. Mol. Neurosci. 21 (2003), 185–189.
11. Benjamins, J.A., Smith, M.E., Metabolism of myelin. Morell, P., (eds.) Myelin, second ed., 1984, Plenum Press, New York, 225–258.
12. Berger, J., Forss-Petter, S., Eichler, F.S., Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 98 (2014), 135–142.
13. Biancheri, R., Zara, F., Bruno, C., Rossi, A., Bordo, L., Gazzerro, E., Sotgia, F., Pedemonte, M., Scapolan, S., Bado, M., Uziel, G., Bugiani, M., Lamba, L.D., Costa, V., Schenone, A., Rozemuller, A.J., Tortori-Donati, P., Lisanti, M.P., van der Knaap, M.S., Minetti, C., Phenotypic characterization of hypomyelination and congenital cataract. Ann. Neurol. 62 (2007), 121–127.
14. Biddle, F., March, E., Miller, J.R., Research news. Mouse News Lett., 48, 1973, 24.
15. Blakemore, W.F., Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1 (1972), 413–426.
16. Blakemore, W.F., Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J. Neurol. Sci. 20 (1973), 63–72.
17. Blakemore, W., Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin. Neuropathol. Appl. Neurobiol. 4 (1978), 47–59.
18. Blakemore, W.F., Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathol. Appl. Neurobiol. 8 (1982), 365–375.
19. Blakemore, W.F., Palmer, A.C., Noel, P.R., Ultrastructural changes in isoniazid-induced brain oedema in the dog. J. Neurocytol. 1 (1972), 263–278.
20. Blanz, J., Schweizer, M., Auberson, M., Maier, H., Muenscher, A., Hubner, C.A., Jentsch, T.J., Leukoencephalopathy upon disruption of the chloride channel ClC-2. J. Neurosci. 27 (2007), 6581–6589.
21. Bonetti, B., Raine, C.S., Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42 (1997), 74–84.
22. Bradl, M., Lassmann, H., Oligodendrocytes: biology and pathology. Acta Neuropathol. 119 (2010), 37–53.
23. Breij, E.C., Brink, B.P., Veerhuis, R., van den, B.C., Vloet, R., Yan, R., Dijkstra, C.D., van, d.V., Bo, L., Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 63 (2008), 16–25.
24. Brok, H.P.M., Bauer, J., Jonker, M., Blezer, E., Amor, S., Bontrop, R.E., Laman, J.D., t Hart, B.A., Non-human primate models of multiple sclerosis. Immunol. Rev. 183 (2001), 173–185.
25. Brown, F.R. III, Voigt, R., Singh, A.K., Singh, I., Peroxisomal disorders. Neurodevelopmental and biochemical aspects. Am. J. Dis. Child. 147 (1993), 617–626.
26. Bruck, W., Herms, J., Brockmann, K., Schulz-Schaeffer, W., Hanefeld, F., Myelinopathia centralis diffusa (vanishing white matter disease): evidence of apoptotic oligodendrocyte degeneration in early lesion development. Ann. Neurol. 50 (2001), 532–536.
27. Bu, J., Banki, A., Wu, Q., Nishiyama, A., Increased NG2 + glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer. Glia 48 (2004), 51–63.
28. Bugiani, M., Postma, N., Polder, E., Dieleman, N., Scheffer, P.G., Sim, F.J., van der Knaap, M.S., Boor, I., Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease. Brain 136 (2013), 209–222.
29. Campagnoni, A.T., Skoff, R.P., The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes. Brain Pathol. 11 (2001), 74–91.
30. Castelvetri, L.C., Givogri, M.I., Zhu, H., Smith, B., Lopez-Rosas, A., Qiu, X., van Breemen, R., Bongarzone, E.R., Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 122 (2011), 35–48.
31. Caulfield, C.D., Kelly, J.P., Jones, B.R., Worrall, S., Conlon, L., Palmer, A.C., Cassidy, J.P., The experimental induction of leukoencephalomyelopathy in cats. Vet. Pathol. 46 (2009), 1258–1269.
32. Chrast, R., Saher, G., Nave, K.A., Verheijen, M.H., Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J. Lipid Res. 52 (2011), 419–434.
33. Clarner, T., Wieczorek, N., Krauspe, B., Jansen, K., Beyer, C., Kipp, M., Astroglial redistribution of aquaporin 4 during spongy degeneration in a Canavan disease mouse model. J. Mol. Neurosci. 53 (2014), 22–30.
34. Coetzee, T., Fujita, N., Dupree, J., Shi, R., Blight, A., Suzuki, K., Suzuki, K., Popko, B., Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86 (1996), 209–219.
35. Compston, A., McDonald, I., Noseworthy, J., Lassmann, H., Miller, D., Smith, K., Wekerle, H., Confavreux, C., McAlpine's Multiple Sclerosis. 2006, Churchill Livingstone Elsevier.
36. Couve, E., Cabello, J.F., Krsulovic, J., Roncagliolo, M., Binding of microtubules to transitional elements in oligodendrocytes of the myelin mutant taiep rat. J. Neurosci. Res. 47 (1997), 573–581.
37. Dal Canto, M.C., Rabinowitz, S., Experimental models of virus-induced demyelination of the central nervous system. Ann. Neurol. 11 (1982), 109–127.
38. Delaney, K.H., Kwiecien, J., Wegiel, J., Wisniewski, H.M., Percy, D.H., Fletch, A.L., Familial dysmyelination in a Long Evans rat mutant. Lab. Anim. Sci. 45 (1995), 547–553.
39. DeLuca, G.C., Nagy, Z., Esiri, M.M., Davey, P., Evidence for a role for apoptosis in central pontine myelinolysis. Acta Neuropathol. (Berl.) 103 (2002), 590–598.
40. Denic, A., Johnson, A.J., Bieber, A.J., Warrington, A.E., Rodriguez, M., Pirko, I., The relevance of animal models in multiple sclerosis research. Pathophysiology 18 (2011), 21–29.
41. Dubois-Dalcq, M., Feigenbaum, V., Aubourg, P., The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci. 22 (1999), 4–12.
42. Duncan, I.D., Toxic Myelinopathies. O'Donoghue, J.L., (eds.) Neurotoxicity of Industrial and Commercial Chemicals, vol. 1, 2, 1985, CRC Press, Boca Raton, 222 S.
43. Duncan, I.D., Inherited disorders of myelination of the central nervous system. Ransom, B.R., Kettenmann, H.R., (eds.) Neuroglial Cells, 1995, Oxford University Press, Cambridge, 990–1009.
44. Duncan, I.D., Brower, A., Kondo, Y., Curlee, J.F. Jr., Schultz, R.D., Extensive remyelination of the CNS leads to functional recovery. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 6832–6836.
45. Duncan, I.D., Hammang, J.P., Goda, S., Quarles, R.H., Myelination in the jimpy mouse in the absence of PLP. Glia 2 (1989), 148–154.
46. Duncan, I.D., Hammang, J.P., Trapp, B.D., Abnormal compact myelin in the myelin-deficient rat: absence of proteolipid protein correlates with a defect in the intraperiod line. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 6287–6291.
47. Duncan, I.D., Kondo, Y., Zhang, S.C., The myelin mutants as models to study myelin repair in the leukodystrophies. Neurotherapeutics 8 (2011), 607–624.
48. Duncan, I.D., Lunn, K.F., Holmgren, B., Urba-Holmgren, R., Brignolo-Holmes, L., The taiep rat: a myelin mutant with an associated oligodendrocyte microtubular defect. J. Neurocytol. 21 (1992), 870–884.
49. Duncan, I.D., Nadon, N.L., Hoffman, R.L., Lunn, K.F., Csiza, C.K., Wells, M.R., Oligodendrocyte survival and function in the long-lived strain of the myelin deficient rat. J. Neurocytol. 24 (1995), 745–762.
50. Ebersole, T.A., Chen, Q., Justice, M.J., Artzt, K., The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat. Genet. 12 (1996), 260–265.
51. Erlich, S.S., Fleming, J.O., Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch. Neurol. 44 (1987), 839–842.
52. Fischer, J.R., Lewis-Weis, L.A., Tate, C.M., Experimental vacuolar myelinopathy in red-tailed hawks. J. Wildl. Dis. 39 (2003), 400–406.
53. Flygt, J., Djupsjo, A., Lenne, F., Marklund, N., Myelin loss and oligodendrocyte pathology in white matter tracts following traumatic brain injury in the rat. Eur. J. Neurosci. 38 (2013), 2153–2165.
54. Francalanci, P., Eymard-Pierre, E., Dionisi-Vici, C., Boldrini, R., Piemonte, F., Virgili, R., Fariello, G., Bosman, C., Santorelli, F.M., Boespflug-Tanguy, O., Bertini, E., Fatal infantile leukodystrophy — a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27. Neurology 57 (2001), 265–270.
55. Frohman, E.M., Racke, M.K., Raine, C.S., Multiple sclerosis—the plaque and its pathogenesis. N. Engl. J. Med. 354 (2006), 942–955.
56. Funfschilling, U., Supplie, L.M., Mahad, D., Boretius, S., Saab, A.S., Edgar, J., Brinkmann, B.G., Kassmann, C.M., Tzvetanova, I.D., Mobius, W., Diaz, F., Meijer, D., Suter, U., Hamprecht, B., Sereda, M.W., Moraes, C.T., Frahm, J., Goebbels, S., Nave, K.A., Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485 (2012), 517–521.
57. Gazzerro, E., Baldassari, S., Giacomini, C., Musante, V., Fruscione, F., La Padula, V., Biancheri, R., Scarfi, S., Prada, V., Sotgia, F., Duncan, I.D., Zara, F., Werner, H.B., Lisanti, M.P., Nobbio, L., Corradi, A., Minetti, C., Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein. PLoS One, 7, 2012, e32180.
58. Geva, M., Cabilly, Y., Assaf, Y., Mindroul, N., Marom, L., Raini, G., Pinchasi, D., Elroy-Stein, O., A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. Brain 133 (2010), 2448–2461.
59. Ghasemlou, N., Jeong, S.Y., Lacroix, S., David, S., T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia 55 (2007), 294–302.
60. Gold, R., Linington, C., Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain, 2006.
61. Graesser, D., Spraker, T.R., Dressen, P., Garner, M.M., T Raymond, J., Terwilliger, G., Kim, J., Madri, J.A., Wobbly Hedgehog Syndrome in African pygmy hedgehogs (Atelerix spp.). J. Exot. Pet. Med. 15 (2006), 59–65.
62. Greco, C.M., Powell, H.C., Garrett, R.S., Lampert, P.W., Cycloleucine encephalopathy. Neuropathol. Appl. Neurobiol. 6 (1980), 349–360.
63. Green, R., Van Tonder, S.V., Oettle, G.J., Cole, G., Metz, J., Neurological changes in fruit bats deficient in vitamin B12. Nature 254 (1975), 148–150.
64. Griffiths, I.R., Klugmann, M., Anderson, T., Thomson, C., Vouyiouklis, D.A., Nave, K.A., Current concepts of PLP and its role in the nervous system. Microsc. Res. Tech. 41 (1998), 344–358.
65. Gruenenfelder, F.I., Thomson, G., Penderis, J., Edgar, J.M., Axon–glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. J. Anat. 219 (2011), 33–43.
66. Gudi, V., Gingele, S., Skripuletz, T., Stangel, M., Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front. Cell. Neurosci., 8, 2014, 73.
67. Guo, F., Bannerman, P., Mills Ko, E., Miers, L., Xu, J., Burns, T., Li, S., Freeman, E., McDonough, J.A., Pleasure, D., Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model. Ann. Neurol. 77 (2015), 884–888.
68. Gupta, N., Henry, R.G., Strober, J., Kang, S.M., Lim, D.A., Bucci, M., Caverzasi, E., Gaetano, L., Mandelli, M.L., Ryan, T., Perry, R., Farrell, J., Jeremy, R.J., Ulman, M., Huhn, S.L., Barkovich, A.J., Rowitch, D.H., Neural stem cell engraftment and myelination in the human brain. Sci. Transl. Med., 4, 2012, 155ra137.
69. Hagen, G., Bjerkas, I., Spongy degeneration of white matter in the central nervous system of silver foxes (Vulpes vulpes). Vet. Pathol. 27 (1990), 187–193.
70. Hagen, G., Blakemore, W.F., Bjerkas, I., Ultrastructural findings in spongy degeneration of white matter in silver foxes (Vulpes vulpes). A naturally occurring demyelinating disease with oligodendrocyte vacuolation. Acta Neuropathol. 80 (1990), 590–596.
71. Hall, S.M., The effect of injections of lysophosphatidyl choline into white metter of the adult mouse spinal cord. J. Cell Sci. 10 (1972), 535–546.
72. Hall, S.M., Gregson, N.A., The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J. Cell Sci. 9 (1971), 769–789.
73. 2 +-permeable TRP channels damage myelin in conditions mimicking ischaemia. Nature 529 (2016), 523–527.
74. Hampton, D.W., Anderson, J., Pryce, G., Irvine, K.A., Giovannoni, G., Fawcett, J.W., Compston, A., Franklin, R.J., Baker, D., Chandran, S., An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J. Neuroimmunol. 201-202 (2008), 200–211.
75. Haroutunian, V., Katsel, P., Roussos, P., Davis, K.L., Altshuler, L.L., Bartzokis, G., Myelination, oligodendrocytes, and serious mental illness. Glia 62 (2014), 1856–1877.
76. Harper, P.A., Healy, P.J., Dennis, J.A., Ultrastructural findings in maple syrup urine disease in Poll Hereford calves. Acta Neuropathol. 71 (1986), 316–320.
77. Herndon, R.M., Rubinstein, L.J., Freeman, J.M., Mathieson, G., Light and electron microscopic observations on Rosenthal fibers in Alexander's disease and in multiple sclerosis. J. Neuropathol. Exp. Neurol. 29 (1970), 524–551.
78. Hesp, Z.C., Goldstein, E.Z., Miranda, C.J., Kaspar, B.K., McTigue, D.M., Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats. J. Neurosci. 35 (2015), 1274–1290.
79. Hess, B., Saftig, P., Hartmann, D., Coenen, R., Lullmann-Rauch, R., Goebel, H.H., Evers, M., von Figura, K., D'Hooge, R., Nagels, G., De Deyn, P., Peters, C., Gieselmann, V., Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci. U. S. A., 93, 1996.
80. Hobson, G.M., Garbern, J.Y., Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin. Neurol. 32 (2012), 62–67.
81. Holmgren, B., Urba-Holmgren, R., Riboni, L., Vega-SaenzdeMiera, E.C., Sprague Dawley rat mutant with tremor, ataxia, tonic immobility episodes, pilepsy and paralysis. Lab. Anim. Sci. 39 (1989), 226–228.
82. Hoshino, H., Kubota, M., Canavan disease: clinical features and recent advances in research. Pediatr. Int. 56 (2014), 477–483.
83. Huang, B., Wei, W.J., Wang, G.H., Gaertig, M.A., Feng, Y., Wang, W., Li, X.J., Li, S.H., Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron 85 (2015), 1212–1226.
84. Huxtable, C.R., Dorling, P.R., Slatter, D.H., Myelin oedema, optic neuropathy and retinopathy in experimental Stypandra imbricata toxicosis. Neuropathol. Appl. Neurobiol. 6 (1980), 221–232.
85. Inoue, Y., Inoue, K., Terashima, T., Mikoshiba, K., Tsukada, Y., Developmental changes of oligodendroglia in the posterior funiculus of “shiverer” mutant mouse spinal cord, with special reference to myelin formation. Anat. Embryol. 168 (1983), 159–171.
86. Irvine, K.A., Blakemore, W.F., Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 175 (2006), 69–76.
87. Izawa, T., Takenaka, S., Ihara, H., Kotani, T., Yamate, J., Franklin, R.J., Kuwamura, M., Cellular responses in the spinal cord during development of hypomyelination in the mv rat. Brain Res. 1195 (2008), 120–129.
88. Jackson, S.J., Lee, J., Nikodemova, M., Fabry, Z., Duncan, I.D., Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. J. Neuropathol. Exp. Neurol. 68 (2009), 616–625.
89. Jacobs, J.M., Cremer, J.E., Cavanagh, J.B., Acute effects of triethyl tin on the rat myelin sheath. Neuropathol. Appl. Neurobiol. 3 (1977), 169–181.
90. Jagessar, S.A., Kap, Y.S., Heijmans, N., van Driel, N., van Straalen, L., Bajramovic, J.J., Brok, H.P., Blezer, E.L., Bauer, J., Laman, J.D., t Hart, B.A., Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant. J. Neuropathol. Exp. Neurol. 69 (2010), 372–385.
91. Jang, J., Kang, H.C., Kim, H.S., Kim, J.Y., Huh, Y.J., Kim, D.S., Yoo, J.E., Lee, J.A., Lim, B., Lee, J., Yoon, T.M., Park, I.H., Hwang, D.Y., Daley, G.Q., Kim, D.W., Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients. Ann. Neurol. 70 (2011), 402–409.
92. Jeffery, N.D., Blakemore, W.F., Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J. Neurocytol. 24 (1995), 775–781.
93. Jellinger, K., Seitelberger, F., Spongy degeneration of the central nervous system in infancy. Curr. Top. Pathol. 53 (1970), 90–160.
94. Jeyakumar, M., Dwek, R.A., Butters, T.D., Platt, F.M., Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. Neurosci. 6 (2005), 713–725.
95. Kassmann, C.M., Lappe-Siefke, C., Baes, M., Brugger, B., Mildner, A., Werner, H.B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., Nave, K.A., Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39 (2007), 969–976.
96. Kaul, R., Gao, G.P., Balamurugan, K., Matalon, R., Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet. 5 (1993), 118–123.
97. Kemp, S., Wanders, R., Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 20 (2010), 831–837.
98. Kerschensteiner, M., Stadelmann, C., Buddeberg, B.S., Merkler, D., Bareyre, F.M., Anthony, D.C., Linington, C., Brück, W., Schwab, M.E., Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am. J. Pathol. 164 (2004), 1455–1469.
99. Kimura, S., Kobayashi, T., Amemiya, F., Myelin splitting in the spongy lesion in Leigh encephalopathy. Pediatr. Neurol. 7 (1991), 56–58.
100. Kipp, M., Clarner, T., Dang, J., Copray, S., Beyer, C., The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118 (2009), 723–736.
101. Kitada, K., Akimitsu, T., Shigematsu, Y., Kondo, A., Maihara, T., Yokoi, N., Kuramoto, T., Sasa, M., Serikawa, T., Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system. J. Neurochem. 74 (2000), 2512–2519.
102. van der Knaap, M.S., Barth, P.G., Gabreëls, F.J.M., Franzoni, E., Begeer, J.H., Stroink, H., Rotteveel, J.J., Valk, J., A new leukoencephalopathy with vanishing white matter. Neurology, 1997, 845–855.
103. van der Knaap, M.S., Leegwater, P.A.J., Könst, A.A.M., Visser, A., Naidu, S., Oudejans, C.B.M., Schutgens, R.B.H., Pronk, J.C., Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann. Neurol. 51 (2002), 264–270.
104. van der Knaap, M., Pronk, J., Scheper, G., Vanishing white matter disease. Lancet Neurol. 5 (2006), 413–423.
105. Kondo, Y., Adams, J.M., Vanier, M.T., Duncan, I.D., Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. J. Neurosci. 31 (2011), 3610–3624.
106. Kondo, A., Sendoh, S., Akazawa, K., Sato, Y., Nagara, H., Early myelination in zitter rat: morphological, immunocytochemical and morphometric studies. Dev. Brain Res. 67 (1992), 217–228.
107. Kovacs, G.G., Hoftberger, R., Majtenyi, K., Horvath, R., Barsi, P., Komoly, S., Lassmann, H., Budka, H., Jakab, G., Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 128 (2005), 35–41.
108. Kuhlmann, T., Lassmann, H., Bruck, W., Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol. 115 (2008), 275–287.
109. Kuramoto, T., Kitada, K., Inui, T., Sasaki, Y., Ito, K., Hase, T., Kawagachi, S., Ogawa, Y., Nakao, K., Barsh, G.S., Nagao, M., Ushijima, T., Serikawa, T., Attractin/mahogany/zitter plays a critical role in myelination of the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 559–564.
110. 2 + channel MRS2 results in demyelination in the rat. PLoS Genet., 7, 2011, e1001262.
111. Kuramoto, T., Nomoto, T., Fujiwara, A., Mizutani, M., Sugimura, T., Ushijima, T., Insertional mutation of the Attractin gene in the black tremor hamster. Mamm. Genome 13 (2002), 36–40.
112. Kuramoto, T., Sotelo, C., Yokoi, N., Serikawa, T., Gonalons Sintes, E., Canto Martorell, J., Guenet, J.L., A rat mutation producing demyelination (dmy) maps to chromosome 17. Mamm. Genome 7 (1996), 890–894.
113. Kuwamura, M., Kanehara, T., Tokuda, S., Kumagai, D., Yamate, J., Kotani, T., Nakane, Y., Kuramoto, T., Serikawa, T., Immunohistochemical and morphometrical studies on myelin breakdown in the demyelination (dmy) mutant rat. Brain Res. 1022 (2004), 110–116.
114. Kuwamura, M., Maeda, M., Kuramoto, T., Kitada, K., Kanehara, T., Moriyama, M., Nakane, Y., Yamate, J., Ushijima, T., Kotani, T., Serikawa, T., The myelin vacuolation (mv) rat with a null mutation in the attractin gene. Lab. Investig. 82 (2002), 1279–1286.
115. Kuypers, N.J., James, K.T., Enzmann, G.U., Magnuson, D.S., Whittemore, S.R., Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Exp. Neurol. 247 (2013), 615–622.
116. Kwiecien, J.M., O'Connor, L.T., Goetz, B.D., Delaney, K.H., Fletch, A.L., Duncan, I.D., Morphological and morphometric studies of the dysmyelinating mutant, the Long Evans shaker rat. J. Neurocytol. 27 (1998), 581–591.
117. Labauge, P., Horzinski, L., Ayrignac, X., Blanc, P., Vukusic, S., Rodriguez, D., Mauguiere, F., Peter, L., Goizet, C., Bouhour, F., Denier, C., Confavreux, C., Obadia, M., Blanc, F., de Seze, J., Fogli, A., Boespflug-Tanguy, O., Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132 (2009), 2161–2169.
118. Lake, N.J., Bird, M.J., Isohanni, P., Paetau, A., Leigh syndrome: neuropathology and pathogenesis. J. Neuropathol. Exp. Neurol. 74 (2015), 482–492.
119. Lassmann, H., Mechanisms of white matter damage in multiple sclerosis. Glia 62 (2014), 1816–1830.
120. Lassmann, H., Brück, W., Lucchinetti, C.F., The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17 (2007), 210–218.
121. Lennon, V.A., Kryzer, T.J., Pittock, S.J., Verkman, A.S., Hinson, S.R., IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202 (2005), 473–477.
122. Lennon, V.A., Wingerchuk, D.M., Kryzer, T.J., Pittock, S.J., Lucchinetti, C.F., Fujihara, K., Nakashima, I., Weinshenker, B.G., A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004), 2106–2112.
123. Li, F.Y., Cuddon, P.A., Song, J., Wood, S.L., Patterson, J.S., Shelton, G.D., Duncan, I.D., Canine spongiform leukoencephalomyelopathy is associated with a missense mutation in cytochrome b. Neurobiol. Dis. 21 (2006), 35–42.
124. Li, F.Y., Song, J., Duncan, I.D., Mapping of taiep rat phenotype to rat chromosome 9. Mamm. Genome 14 (2003), 703–705.
125. Lin, Y., Pang, X., Huang, G., Jamison, S., Fang, J., Harding, H.P., Ron, D., Lin, W., Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the pathology of vanishing white matter disease in mice. J. Neurosci. 34 (2014), 12182–12191.
126. Lindner, M., Fokuhl, J., Linsmeier, F., Trebst, C., Stangel, M., Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci. Lett. 453 (2009), 120–125.
127. Locatelli, G., Wortge, S., Buch, T., Ingold, B., Frommer, F., Sobottka, B., Kruger, M., Karram, K., Buhlmann, C., Bechmann, I., Heppner, F.L., Waisman, A., Becher, B., Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat. Neurosci. 15 (2012), 543–550.
128. Lucchinetti, C., Brück, W., Parisi, J., Scheithauer, B., Rodrigues, M., Lassmann, H., Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47 (2000), 707–717.
129. Lucchinetti, C.F., Brück, W., Rodriguez, M., Lassmann, H., Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6 (1996), 259–274.
130. Lucchinetti, C.F., Guo, Y., Popescu, B.F., Fujihara, K., Itoyama, Y., Misu, T., The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol. 24 (2014), 83–97.
131. Ludwin, S.K., Chronic demyelination inhibits remyelination in the central nervous system. Lab. Investig. 43 (1980), 382–387.
132. van der Lugt, J.J., Venter, I., Myelin vacuolation, optic neuropathy and retinal degeneration after closantel overdosage in sheep and in a goat. J. Comp. Pathol. 136 (2007), 87–95.
133. Lunn, K.F., Fanarraga, M., Duncan, I.D., Myelin mutants: new models and new observations. Microsc. Res. Tech., 183–203, 1995.
134. Lunn, K.F., Clayton, M.K., Duncan, I.D., The temporal progression of the myelination defect in the taiep rat. J. Neurocytol. 26 (1997), 267–281.
135. Lutz, S.E., Zhao, Y., Gulinello, M., Lee, S.C., Raine, C.S., Brosnan, C.F., Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J. Neurosci. 29 (2009), 7743–7752.
136. Maier, H., Wang-Eckhardt, L., Hartmann, D., Gieselmann, V., Eckhardt, M., N-acetylaspartate synthase deficiency Corrects the myelin phenotype in a Canavan disease mouse model but does not affect survival time. J. Neurosci. 35 (2015), 14501–14516.
137. Matsushima, G.K., Morell, P., The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11 (2001), 107–116.
138. Matsushima, G.K., Taniike, M., Glimcher, L.H., Grusby, M.J., Frelinger, J.A., Suzuki, K., Ting, J.P.Y., Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 78 (1994), 645–656.
139. Matthieu, J.M., Omlin, F.X., Ginalski-Winkelmann, H., Cooper, B.J., Myelination in the CNS of mld mutant mice: comparison between composition and structure. Brain Res. 315 (1984), 149–158.
140. Mayer, J.A., Griffiths, I.R., Goldman, J.E., Smith, C.M., Cooksey, E., Radcliff, A.B., Duncan, I.D., Modeling the natural history of Pelizaeus-Merzbacher disease. Neurobiol. Dis. 75 (2015), 115–130.
141. McCaddon, A., Vitamin B12 in neurology and ageing; clinical and genetic aspects. Biochimie 95 (2013), 1066–1076.
142. McTigue, D.M., Tripathi, R.B., The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 107 (2008), 1–19.
143. Mecha, M., Carrillo-Salinas, F.J., Mestre, L., Feliu, A., Guaza, C., Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus. Prog. Neurobiol. 101-102 (2013), 46–64.
144. Menichella, D.M., Majdan, M., Awatramani, R., Goodenough, D.A., Sirkowski, E., Scherer, S.S., Paul, D.L., Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J. Neurosci. 26 (2006), 10984–10991.
145. Merkler, D., Schmelting, B., Czeh, B., Fuchs, E., Stadelmann, C., Bruck, W., Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult. Scler. 12 (2006), 369–374.
146. Messing, A., Brenner, M., Feany, M.B., Nedergaard, M., Goldman, J.E., Alexander disease. J. Neurosci. 32 (2012), 5017–5023.
147. Messing, A., Head, M.W., Galles, K., Galbreath, E., Goldman, J.E., Brenner, M., Fatal encephalopathy with astroyte inclusions in GFAP transgenic mice. Am. J. Pathol. 152 (1998), 391–398.
148. Mierzwa, A.J., Marion, C.M., Sullivan, G.M., McDaniel, D.P., Armstrong, R.C., Components of myelin damage and repair in the progression of white matter pathology after mild traumatic brain injury. J. Neuropathol. Exp. Neurol. 74 (2015), 218–232.
149. Mignot, C., Boespflug-Tanguy, O., Gelot, A., Dautigny, A., Pham-Dinh, D., Rodriguez, D., Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell. Mol. Life Sci. 61 (2004), 369–385.
150. Mikoshiba, K., Aruga, J., Ikenaka, K., Okano, H., Shiverer and allelic mutant MLD mice. RE, M., (eds.) Myelin: Biology and Chemistry, 1992, CRC Press, Boca Raton, FL, 723–744.
151. Miller, A., Korem, M., Almog, R., Galboiz, Y., Vitamin B12, demyelination, remyelination and repair in multiple sclerosis. J. Neurol. Sci. 233 (2005), 93–97.
152. Misu, T., Hoftberger, R., Fujihara, K., Wimmer, I., Takai, Y., Nishiyama, S., Nakashima, I., Konno, H., Bradl, M., Garzuly, F., Itoyama, Y., Aoki, M., Lassmann, H., Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol. 125 (2013), 815–827.
153. Mobius, W., Nave, K.A., Werner, H.B., Electron microscopy of myelin: structure preservation by high-pressure freezing. Brain Res., 2016.
154. Morato, L., Bertini, E., Verrigni, D., Ardissone, A., Ruiz, M., Ferrer, I., Uziel, G., Pujol, A., Mitochondrial dysfunction in central nervous system white matter disorders. Glia 62 (2014), 1878–1894.
155. Morell, P., Quarles, R.H., Norton, W.T., Myelin formation, structure, and biochemistry. Siegel, G.J., (eds.) Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, fifth ed., 1994, Raven Press, New York, 117–143.
156. Mori, S., Leblond, C.P., Electron microscopic identification of three classes of oligodendrocytes and a preliminary study of their activity in the corpus callosum of young rats. J. Comp. Neurol. 139 (1970), 1–30.
157. Morrison, B.M., Lee, Y., Rothstein, J.D., Oligodendroglia: metabolic supporters of axons. Trends Cell Biol. 23 (2013), 644–651.
158. Moser, H.W., Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120 (1997), 1485–1508.
159. Musolino, P.L., Gong, Y., Snyder, J.M., Jimenez, S., Lok, J., Lo, E.H., Moser, A.B., Grabowski, E.F., Frosch, M.P., Eichler, F.S., Brain endothelial dysfunction in cerebral adrenoleukodystrophy. Brain 138 (2015), 3206–3220.
160. Nagara, H., Suzuki, K., Chronological study of oligodendroglial alterations and myelination in quaking mice. Neuropathol. Appl. Neurobiol. 7 (1981), 135–149.
161. Nave, K.A., Myelination and support of axonal integrity by glia. Nature 468 (2010), 244–252.
162. Nave, K.A., Ehrenreich, H., Myelination and oligodendrocyte functions in psychiatric diseases. JAMA Psychiatry 71 (2014), 582–584.
163. Nave, K.A., Werner, H.B., Myelination of the nervous system: mechanisms and functions. Annu. Rev. Cell Dev. Biol. 30 (2014), 503–533.
164. O'Connor, L.T., Goetz, B.D., Couve, E., Song, J., Duncan, I.D., Intracellular distribution of myelin protein gene products is altered in oligodendrocytes of the taiep rat. Mol. Cell. Neurosci. 16 (2000), 396–407.
165. O'Connor, L.T., Goetz, B.D., Kwiecien, J.M., Delaney, K.H., Fletch, A.L., Duncan, I.D., Insertion of a retrotransposon in Mbp disrupts mRNA splicing and myelination in a new mutant rat. J. Neurosci. 19 (1999), 3404–3413.
166. Oldfors, A., Tulinius, M., Mitochondrial encephalomyopathies. J. Neuropathol. Exp. Neurol. 62 (2003), 217–227.
167. Oldfors, A., Fyhr, I.M., Holme, E., Larsson, N.G., Tulinius, M., Neuropathology in Kearns–Sayre syndrome. Acta Neuropathol. 80 (1990), 541–546.
168. Olmos-Serrano, J.L., Kang, H.J., Tyler, W.A., Silbereis, J.C., Cheng, F., Zhu, Y., Pletikos, M., Jankovic-Rapan, L., Cramer, N.P., Galdzicki, Z., Goodliffe, J., Peters, A., Sethares, C., Delalle, I., Golden, J.A., Haydar, T.F., Sestan, N., Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron 89 (2016), 1208–1222.
169. O'Sullivan, B.M., Blakemore, W.F., Acute nicotinamide deficiency in the pig induced by 6-aminonicotinamide. Vet. Pathol. 17 (1980), 748–758.
170. Padiath, Q.S., Saigoh, K., Schiffmann, R., Asahara, H., Yamada, T., Koeppen, A., Hogan, K., Ptacek, L.J., Fu, Y.H., Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat. Genet. 38 (2006), 1114–1123.
171. Palmer, A.C., Blakemore, W.F., Franklin, R.J., Frost, L.M., Gough, R.E., Lewis, J.C., Macdougall, D.F., O'Leary, M.T., Stocker, L.R., Paralysis in hedgehogs (Erinaceus europaeus) associated with demyelination. Vet. Rec. 143 (1998), 550–552.
172. Panagiotakos, G., Alshamy, G., Chan, B., Abrams, R., Greenberg, E., Saxena, A., Bradbury, M., Edgar, M., Gutin, P., Tabar, V., Long-term Impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One, 2, 2007.
173. Papadopoulos, D., Pham-Dinh, D., Reynolds, R., Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp. Neurol. 197 (2006), 373–385.
174. Peters, A., Palay, S.L., Webster, H.d., The Fine Structure of the Nervous System: Neurons and their Supporting Cells. third ed, 1991, Oxford Univ. Press, New York U.A.
175. Pfeiffer, S.E., Warrington, A.E., Bansal, R., The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3 (1993), 191–197.
176. Piao, J., Major, T., Auyeung, G., Policarpio, E., Menon, J., Droms, L., Gutin, P., Uryu, K., Tchieu, J., Soulet, D., Tabar, V., Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell 16 (2015), 198–210.
177. Piao, J.H., Wang, Y., Duncan, I.D., CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord. Glia 61 (2013), 361–367.
178. Plemel, J.R., Keough, M.B., Duncan, G.J., Sparling, J.S., Yong, V.W., Stys, P.K., Tetzlaff, W., Remyelination after spinal cord injury: is it a target for repair?. Prog. Neurobiol. 117 (2014), 54–72.
179. Popko, B., A novel mutation in myelin-deficient mice results in unstable myelin basic protein gene transcripts. Neuron 1 (1988), 221–225.
180. Popovich, P.G., Guan, Z., McGaughy, V., Fisher, L., Hickey, W.F., Basso, D.M., The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J. Neuropathol. Exp. Neurol. 61 (2002), 623–633.
181. Powers, J.M., Moser, H.W., Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions and pathogenesis. Brain Pathol. 8 (1998), 101–120.
182. Powers, J.M., DeCiero, D.P., Ito, M., Moser, A.B., Moser, H.W., Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J. Neuropathol. Exp. Neurol. 59 (2000), 89–102.
183. Prineas, J., The neuropathology of multiple sclerosis. Vinken, P.J., Bruyn, G.W., Klawans, H.L., Koetsier, J.C., (eds.) Handbook of Clinical Neurology/Vol. 47, Demyelinating Diseases/Co-edited by Johan C. Koetsier, 1985, Elsevier, Amsterdam, xii (660 pages).
184. Pujol, A., Hindelang, C., Callizot, N., Bartsch, U., Schachner, M., Mandel, J.L., Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 11 (2002), 499–505.
185. Raine, C.S., Cannella, B., Hauser, S.L., Genain, C.P., Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46 (1999), 144–160.
186. Ramakrishnan, H., Hedayati, K.K., Lullmann-Rauch, R., Wessig, C., Fewou, S.N., Maier, H., Goebel, H.H., Gieselmann, V., Eckhardt, M., Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. J. Neurosci. 27 (2007), 9482–9490.
187. Ransohoff, R.M., Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15 (2012), 1074–1077.
188. Rehm, S., Mehraein, P., Anzil, A.P., Deerberg, F., A new rat mutant with defective overhairs and spongy degeneration of the central nervous system: clinical and pathologic studies. Lab. Anim. Sci. 32 (1982), 70–73.
189. Richardson, W.D., Kessaris, N., Pringle, N., Oligodendrocyte wars. Nat. Rev. Neurosci. 7 (2006), 11–18.
190. Rizzuto, N., Gambetti, P.L., Status spongiosus of rat central nervous system induced by actinomycin D. Acta Neuropathol. 36 (1976), 21–30.
191. Rodriguez, D., Gelot, A., Della Gaspera, B., Robain, O., Ponsot, G., SarliŠve, L.L., Ghandour, S., Pompidou, A., Dautigny, A., Aubourg, P., Pham-Dinh, D., Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases. Acta Neuropathol. (Berl) 97 (1999), 469–480.
192. Rojiani, A.M., Prineas, J.W., Cho, E.S., Electrolyte-induced demyelination in rats. 1. Role of the blood–brain barrier and edema. Acta Neuropathol. (Berl) 88 (1994), 287–292.
193. Rolyan, H., Tyurina, Y.Y., Hernandez, M., Amoscato, A.A., Sparvero, L.J., Nmezi, B.C., Lu, Y., Estecio, M.R., Lin, K., Chen, J., He, R.R., Gong, P., Rigatti, L.H., Dupree, J., Bayir, H., Kagan, V.E., Casaccia, P., Padiath, Q.S., Defects of lipid synthesis are linked to the age-dependent demyelination caused by Lamin B1 overexpression. J. Neurosci. 35 (2015), 12002–12017.
194. Sachs, H.H., Bercury, K.K., Popescu, D.C., Narayanan, S.P., Macklin, W.B., A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro, 6, 2014.
195. Sakakibara, S., Nakadate, K., Ookawara, S., Ueda, S., Non-cell autonomous impairment of oligodendrocyte differentiation precedes CNS degeneration in the Zitter rat: implications of macrophage/microglial activation in the pathogenesis. BMC Neurosci., 9, 2008, 35.
196. Sasaki, M., Lankford, K.L., Brown, R.J., Ruddle, N.H., Kocsis, J.D., Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor. Glia 58 (2010), 1523–1531.
197. Scalabrino, G., Lorenzini, E.C., Monzio-Compagnoni, B., Colombi, R.P., Chiodini, E., Buccellato, F.R., Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction. Lab. Investig. 72 (1995), 114–123.
198. Schiffmann, R., Moller, J.R., Trapp, B.D., Shih, H.H.L., Farrer, R.G., Katz, D.A., Alger, J.R., Parker, C.C., Hauer, P.E., Kaneshi, C.R., Heiss, J.D., Kaye, E.M., Quarles, R.H., Brady, R.O., Barton, N.W., Childhood ataxia with diffuse central nervous system hypomyelination. Ann. Neurol. 35 (1994), 331–340.
199. Schobesberger, M., Zurbriggen, A., Doherr, M.G., Weissenb”ck, H., Vandevelde, M., Lassmann, H., Griot, C., Demyelination precedes oligodendrocyte loss in canine distemper virus-induced encephalitis. Acta Neuropathol. (Berl.) 103 (2002), 11–19.
200. Schonberg, D.L., Popovich, P.G., McTigue, D.M., Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J. Neuropathol. Exp. Neurol. 66 (2007), 1124–1135.
201. Seehusen, F., Baumgartner, W., Axonal pathology and loss precede demyelination and accompany chronic lesions in a spontaneously occurring animal model of multiple sclerosis. Brain Pathol. 20 (2010), 551–559.
202. Simons, M., Nave, K.A., Oligodendrocytes: myelination and axonal support. Cold Spring Harb. Perspect. Biol., 8, 2015.
203. Skripuletz, T., Bussmann, J.H., Gudi, V., Koutsoudaki, P.N., Pul, R., Moharregh-Khiabani, D., Lindner, M., Stangel, M., Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol. 20 (2010), 301–312.
204. Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., Stangel, M., Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172 (2008), 1053–1061.
205. Smith, P.M., Jeffery, N.D., Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol. 16 (2006), 99–109.
206. Smith, C.M., Cooksey, E., Duncan, I.D., Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination. J. Neurosci. 33 (2013), 2718–2727.
207. Smith, C.M., Mayer, J.A., Duncan, I.D., Autophagy promotes oligodendrocyte survival and function following dysmyelination in a long-lived myelin mutant. J. Neurosci. 33 (2013), 8088–8100.
208. Song, J., Carson, J.H., Barbarese, E., Li, F.Y., Duncan, I.D., RNA transport in oligodendrocytes from the taiep mutant rat. Mol. Cell. Neurosci. 24 (2003), 926–938.
209. Song, J., O'Connor, L.T., Yu, W., Baas, P.W., Duncan, I.D., Microtubule alterations in cultured taiep rat oligodendrocytes lead to deficits in myelin membrane formation. J. Neurocytol. 28 (1999), 671–683.
210. Southwood, C.M., Garbern, J., Jiang, W., Gow, A., The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36 (2002), 585–596.
211. Sparaco, M., Bonilla, E., Dimauro, S., Powers, J.M., Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J. Neuropathol. Exp. Neurol. 52 (1993), 1–10.
212. Stadelmann, C., Wegner, C., Bruck, W., Inflammation, demyelination, and degeneration — recent insights from MS pathology. Biochim. Biophys. Acta 1812 (2011), 275–282.
213. Stassart, R.M., Helms, G., Garea-Rodriguez, E., Nessler, S., Hayardeny, L., Wegner, C., Schlumbohm, C., Fuchs, E., Bruck, W., A new targeted model of experimental autoimmune encephalomyelitis in the common marmoset. Brain Pathol., 2015.
214. Steelman, A.J., Thompson, J.P., Li, J., Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci. Res. 72 (2012), 32–42.
215. Steinman, L., Zamvil, S.S., How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 (2006), 12–21.
216. Stidworthy, M.F., Genoud, S., Suter, U., Mantei, N., Franklin, R.J.M., Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13 (2003), 329–339.
217. Stohlman, S.A., Hinton, D.R., Viral induced demyelination. Brain Pathol. 11 (2001), 92–106.
218. Storch, M.K., Stefferl, A., Brehm, U., Weissert, R., Wallstr”m, E., Kerschensteiner, M., Olsson, T., Linington, C., Lassmann, H., Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8 (1998), 681–694.
219. Stys, P.K., Zamponi, G.W., van Minnen, J., Geurts, J.J., Will the real multiple sclerosis please stand up?. Nat. Rev. Neurosci. 13 (2012), 507–514.
220. Suzuki, K., A genetic demyelinating disease globoid cell leukodystrophy: studies with animal models. J. Neuropathol. Exp. Neurol. 53 (1994), 359–363.
221. Suzuki, K., Taniike, R., Murine model of genetic demyelinating disease: The twitcher mouse. Microsc. Res. Tech. 32 (1995), 204–214.
222. Tanaka, M., Izawa, T., Yamate, J., Franklin, R.J., Kuramoto, T., Serikawa, T., Kuwamura, M., The VF rat with abnormal myelinogenesis has a mutation in Dopey1. Glia 62 (2014), 1530–1542.
223. Tanaka, M., Soma, K., Izawa, T., Yamate, J., Franklin, R.J., Kuramoto, T., Serikawa, T., Kuwamura, M., Abnormal myelinogenesis in the central nervous system of the VF mutant rat with recoverable tremor. Brain Res. 1488 (2012), 104–112.
224. Taniike, M., Suzuki, K., Spacio-temporal progression of demyelination in twitcher mouse: with clinico-pathological correlation. Acta Neuropathol. (Berl) 88 (1994), 228–236.
225. Taniike, M., Mohri, I., Eguchi, N., Irikura, D., Urade, Y., Okada, S., Suzuki, K., An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy. J. Neuropathol. Exp. Neurol. 58 (1999), 644–653.
226. Teixeira, C.A., Miranda, C.O., Sousa, V.F., Santos, T.E., Malheiro, A.R., Solomon, M., Maegawa, G.H., Brites, P., Sousa, M.M., Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease. Neurobiol. Dis. 66 (2014), 92–103.
227. Tellez, I., Johnson, D., Nagel, R.L., Cerami, A., Neurotoxicity of sodium cyanate. New pathological and ultrastructural observations in Maccaca nemestrina. Acta Neuropathol. 47 (1979), 75–79.
228. Thomas, N.J., Meteyer, C.U., Sileo, L., Epizootic vacuolar myelinopathy of the central nervous system of bald eagles (Haliaeetus leucocephalus) and American coots (Fulica americana). Vet. Pathol. 35 (1998), 479–487.
229. Towfighi, J., Gonatas, N.K., Hexachlorophene and the nervous system. Zimmerman, H.M., (eds.) Progress in Neuropathology, vol. 3, 1976, Grune and Stratton, New York; London, xii (495 pages).
230. Towfighi, J., Gonatas, N.K., McCree, L., Hexachlorophene-induced changes in central and peripheral myelinated axons of developing and adult rats. Lab. Investig. 31 (1974), 712–721.
231. Traka, M., Podojil, J.R., McCarthy, D.P., Miller, S.D., Popko, B., Oligodendrocyte death results in immune-mediated CNS demyelination. Nat. Neurosci., 2015.
232. Traka, M., Wollmann, R.L., Cerda, S.R., Dugas, J., Barres, B.A., Popko, B., Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J. Neurosci. 28 (2008), 11537–11549.
233. Trapp, B.D., Nave, K.A., Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 31 (2008), 247–269.
234. Tripier, M.F., Berard, M., Toga, M., Martin-Bouyer, G., Le Breton, R., Garat, J., Hexachlorophene and the central nervous system. Toxic effects in mice and baboons. Acta Neuropathol. 53 (1981), 65–74.
235. Tsunoda, I., Fujinami, R.S., Inside-out versus outside-in model for virus induced demyelination: axonal damage triggering demyelination. Springer Semin. Immunopathol. 24 (2002), 105–125.
236. Tsutsui, S., Stys, P.K., Metabolic injury to axons and myelin. Exp. Neurol. 246 (2013), 26–34.
237. Van der Knaap, M.S., Valk, J., Alexander disease. Van der Knaap, M.S., Valk, J., (eds.) Magnetic Resonance of Myelination and Myelin Disorders, third ed., 2005, Springer-Verlag Berlin and Heidelberg & Co. KG, Dordrecht (p. 1 online resource 1096 pages).
238. Von Figura, K., Gieselmann, V., Jaeken, J., Metachromatic leukodystrophy. Scriver, C.R., Beaudet, A.L., Valle, D., Sly, W.S., (eds.) The Metabolic and Molecular Bases of Inherited Disease, eighth ed., 2001, ed. McGraw-Hill, New York; Madrid; Milan etc., 3695–3724.
239. Wang, Y., Piao, J.H., Larsen, E.C., Kondo, Y., Duncan, I.D., Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation. J. Neurosci. Res., 2011.
240. Wang, X.M., Yik, W.Y., Zhang, P., Lu, W., Dranchak, P.K., Shibata, D., Steinberg, S.J., Hacia, J.G., The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis. Stem Cell. Res. Ther., 3, 2012, 39.
241. Watanabe, I., Organotin (triethyltin). Spencer, P.S., Schaumburg, H.H., (eds.) Experimental and Clinical Neurotoxicology, 1980, Williams & Wilkins, Baltimore, 545–557.
242. Wenger, D.A., Murine, canine and non-human primate models of Krabbe disease. Mol. Med. Today 6 (2000), 449–451.
243. Wenger, D.A., Rafi, M.A., Luzi, P., Datto, J., Costantino-Ceccarini, E., Krabbe disease: genetic aspects and progress toward therapy. Mol. Genet. Metab. 70 (2000), 1–9.
244. Werner, H., Jung, M., Klugmann, M., Sereda, M., Griffiths, I.R., Nave, K.A., Mouse models of myelin diseases. Brain Pathol. 8 (1998), 771–793.
245. Wu, Q.Z., Yang, Q., Cate, H.S., Kemper, D., Binder, M., Wang, H.X., Fang, K., Quick, M.J., Marriott, M., Kilpatrick, T.J., Egan, G.F., MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J. Magn. Reson. Imaging 27 (2008), 446–453.
246. Xie, M., Tobin, J.E., Budde, M.D., Chen, C.I., Trinkaus, K., Cross, A.H., McDaniel, D.P., Song, S.K., Armstrong, R.C., Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 69 (2010), 704–716.
247. Yaghootfam, A., Gieselmann, V., Eckhardt, M., Delay of myelin formation in arylsulphatase A-deficient mice. Eur. J. Neurosci. 21 (2005), 711–720.
248. Yajima, K., Suzuki, K., Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab. Investig., 1979, 385–392.
249. Yajima, K., Suzuki, K., Ultrastructural changes of oligodendroglia and myelin sheaths induced by ethidium bromide. Neuropathol. Appl. Neurobiol. 5 (1979), 49–62.
250. Young, N.P., Weinshenker, B.G., Parisi, J.E., Scheithauer, B., Giannini, C., Roemer, S.F., Thomsen, K.M., Mandrekar, J.N., Erickson, B.J., Lucchinetti, C.F., Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 133 (2010), 333–348.
251. Zachary, J.F., O'Brien, D.P., Spongy degeneration of the central nervous system in two canine littermates. Vet. Pathol. 22 (1985), 561–571.
252. Zara, F., Biancheri, R., Bruno, C., Bordo, L., Assereto, S., Gazzerro, E., Sotgia, F., Wang, X.B., Gianotti, S., Stringara, S., Pedemonte, M., Uziel, G., Rossi, A., Schenone, A., Tortori-Donati, P., van der Knaap, M.S., Lisanti, M.P., Minetti, C., Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract. Nat. Genet. 38 (2006), 1111–1113.
253. Zhao, L., Tian, D., Xia, M., Macklin, W.B., Feng, Y., Rescuing qkV dysmyelination by a single isoform of the selective RNA-binding protein QKI. J. Neurosci. 26 (2006), 11278–11286.